General Catalyst leads Series D round for Rakuten Medical

Rakuten Medical, Inc., a global clinical stage biotechnology company, has raised $166 million in Series D financing.

Rakuten Medical, Inc., a global clinical stage biotechnology company, has raised $166 million in Series D financing. General Catalyst led the round with participation from other investors including Rakuten Group and SBI Group.

Source: Press Release